Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum and synovial fluid IgG, IgA and IgM antigammaglobulins in rheumatoid arthritis.

× No keyword cloud information.

27 in total

1. Effect of rheumatoid factor and anti-immunoglobulin G antibodies on complement-mediated lysis of herpes simplex virus-infected human fibroblasts.

Authors: J C Shivers; C A Daniels
Journal: Infect Immun Date: 1977-02 Impact factor: 3.441

2. Metabolism of autologous and homologous IgG in rheumatoid arthritis.

Authors: M A Catalano; E H Krick; D H De Heer; R M Nakamura; A N Theofilopoulos; J H Vaughan
Journal: J Clin Invest Date: 1977-08 Impact factor: 14.808

3. A study of complement fixation by rheumatoid factor using a haemolytic assay system.

Authors: M M Taylor-Upsahl; P M Johnson; O J Mellbye; J B Natvig
Journal: Clin Exp Immunol Date: 1977-05 Impact factor: 4.330

4. Detection of IgG rheumatoid factor by concanavalin A treatment and complement fixation with IgG rheumatoid factor.

Authors: K Tanimoto; T Moritoh; T Azuma; Y Horiuchi
Journal: Ann Rheum Dis Date: 1976-06 Impact factor: 19.103

5. Assessment of rheumatoid activity based on clinical features and blood and synovial fluid analysis.

Authors: M Farr; M J Kendall; D W Young; M J Meynell; C F Hawkins
Journal: Ann Rheum Dis Date: 1976-04 Impact factor: 19.103

6. Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.

Authors: E C Böttger; T Hoffmann; U Hadding; D Bitter-Suermann
Journal: J Clin Invest Date: 1986-09 Impact factor: 14.808

7. IgG anti-IgG antibodies in rheumatoid arthritis and certain other conditions.

Authors: J L Abruzzo; R Heimer
Journal: Ann Rheum Dis Date: 1974-05 Impact factor: 19.103

8. Differential use of immunoglobulin light chain genes and B lymphocyte expansion at sites of disease in rheumatoid arthritis (RA) compared with circulating B lymphocytes.

Authors: S P Moyes; R N Maini; R A Mageed
Journal: Clin Exp Immunol Date: 1998-08 Impact factor: 4.330

9. Antiglobulins in Nigerians with rheumatoid disease.

Authors: G O Okafor; M W Turner; B M Greenwood
Journal: Ann Rheum Dis Date: 1975-04 Impact factor: 19.103

10. Human mononuclear cells and neutral proteinases. III. Neutral proteinases and rheumatoid arthritis: monocytes as a source of cathepsin G and proteinase potentiation of IgM rheumatoid factor elaboration.

Authors: R S Panush
Journal: Inflammation Date: 1989-06 Impact factor: 4.092